Autolus Therapeutics PLC
F:6A3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Autolus Therapeutics PLC
F:6A3A
|
UK |
|
N
|
Nippon Paint Holdings Co Ltd
XBER:NI7
|
JP |
|
G
|
Glow Lifetech Corp
F:9DO
|
CA |
|
M
|
MyMD Pharmaceuticals Inc
F:DQS
|
US |
|
Nerdwallet Inc
F:6OI
|
US |
|
I
|
Imagine Lithium Inc
F:37N
|
CA |
|
Caspar Asset Management SA
F:6QA
|
PL |
|
C
|
Cts Eventim AG & Co KgaA
SWB:EVD
|
DE |
|
Cerro Grande Mining Corp
OTC:CEGMF
|
CL |
|
Y
|
Yokogawa Electric Corp
F:YKE
|
JP |
|
Spey Resources Corp
F:2JS
|
CA |
|
Pyridam Farma Tbk PT
IDX:PYFA
|
ID |
Bankruptcy Probability
Autolus Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Autolus Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
622.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Autolus Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Autolus Therapeutics PLC has total debt of 271.4m USD. This includes both short-term (0 USD) and long-term (271.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
